Loading ......
Filter By Product Search for
ALX4
ALX4 Full Name
ALX homeobox 4
ALX4 Introduction
ALX4 encodes a paired-class homeodomain transcription factor that serves as a critical regulator of skull vault and appendicular skeleton development. The ALX4 protein shares a highly conserved 60-amino-acid homeodomain with its family members ALX1 and ALX3, through which it binds regulatory DNA sequences and modulates transcription of target genes controlling mesenchymal cell fate and osteoblast differentiation. ALX4 is expressed predominantly in the mesenchyme of the skull vault, particularly in the osteogenic fronts of the coronal and sagittal sutures, as well as in the mesenchyme of the frontonasal process and limb buds. Within these domains, ALX4 acts downstream of BMP and Msx transcription factors to promote osteogenic differentiation and to maintain the proliferative balance required for proper suture closure. Haploinsufficiency of ALX4 in humans disrupts this tightly regulated program, leading to premature fusion of cranial sutures and characteristic skull defects.
Figure 1. Alx4 mutations result in decreased expression or expression regions of several transcription factor genes. (Source: Matsumaru D, et al. 2014)
Heterozygous loss-of-function mutations in ALX4 are classically associated with parietal foramina, characterized by symmetric bilateral openings in the parietal bones near the sagittal suture. These "foramina" can range from small pits to large oval defects several centimeters in diameter, and are typically covered only by skin and dura mater. PFM is usually an isolated finding, though it may cosegregate with frontonasal dysplasia type 1 when additional cranial vault or facial midline structures are involved. In rare instances, homozygous ALX4 mutations cause a more severe syndrome with expanded forebrain defects. The phenotypic variability in ALX4-related disorders reflects the degree of residual ALX4 function: haploinsufficiency sufficient to disrupt suture osteogenesis produces PFM, whereas more complete loss-of-function perturbs broader midline craniofacial development. Surgical management of large parietal foramina may be indicated to protect against traumatic injury to underlying neural tissue.
Alternate Names for ALX4
ALX4; ALX homeobox 4; aristaless like homeobox 4; parietal foramina 2; PFM2; homeobox protein aristaless-like 4; FPP; KIAA1788; PFM; aristaless-like homeobox 4; homeodomain transcription factor ALX4; FND2;
Loading ......